Star Scientific Hunky-Dory with FDA Ruling

Star Scientific Inc. (NASDAQ: CIGX) shared gained 10% on the day after the company announced the receipt of notices from the Food and Drug Administration regarding its pending ARIVA-BDL and STONEWALL-BDL modified risk tobacco product applications. The notices from Lawrence Deyton, MD, MSPH, director of the FDA Center for Tobacco Products (CTP), said, Not all tobacco products are currently subject to Chapter IX of the FDCA [Federal Food Drug & Cosmetic Act]. At this time, only cigarettes, cigarette tobacco, smokeless tobacco and roll-your-own tobacco are subject to Chapter IX FDCA Section 901(b). Based upon the information in your submission, [ARIVA-BDL and Stonewall-BDL are] not currently subject to Chapter IX requirements.

The company can now proceed with marketing these products following the FDAs determination that Ariva-BDL and Stonewall-BDL tobacco lozenges are not tobacco products that are currently regulated under Chapter IX of the FDCA.

Paul L. Perito, Stars chairman, president and COO, commented, We are pleased to have received a determination from the FDA on Ariva-BDL and Stonewall-BDL. It is clear from the notices we received that the Center for Tobacco Products does not believe these products are subject to regulation under FDC Act Chapter IX at this time. We intend to move forward with marketing and distribution of Ariva-BDL and Stonewall BDL, and these initiatives will be undertaken consistent with our belief that adult tobacco users should be able to have information about the toxin levels in all tobacco products.

  • This newsletter has been helping traders make a killing on CIGX. Click here for a 25% discount offer.
  • See todays top stock picks and market analysis
  • Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
  • Want more? Check out the message board buzz for CIGX
  • See what newsletters are recommending this stock pick
  • Get breaking news alerts on these stocks:

 

 

Similar Posts:

Share

Leave a Reply